Posted inNews and Updates
Intensity Therapeutics Resumes INVINCIBLE-4 Cancer Trial
Intensity Therapeutics has resumed its INVINCIBLE-4 Phase 2 trial for triple-negative breast cancer. Discover the latest on this innovative cancer study.
Posted inNews and Updates
Clinical Trials Market Projected to Hit $176B by 2030
The clinical trials market is set to hit $176B by 2030. Discover how AI and decentralized research models are accelerating drug development worldwide.
Posted inNews and Updates
FDA Clears Clinical Trial for Novel ATR 1072 Treatment
The FDA has authorized Atrium’s IND application for ATR 1072. Learn about this new clinical trial milestone and the future of this therapeutic development.
Posted inNews and Updates
Sound Pharmaceuticals Completes SPI-1005 Clinical Trial
Sound Pharmaceuticals has wrapped up enrollment for its Phase 3 SPI-1005 trial, targeting new treatments for sensorineural hearing loss and Meniere’s disease.
Posted inNews and Updates
New ALS Drug Shows Promise in Phase 1 Clinical Trial
Researchers report promising safety and biomarker results in a Phase 1 trial for a new siRNA-based treatment targeting SOD1-associated ALS.
Posted inNews and Updates
Vietnam Pharma Market to Hit $10B: Growth Drivers Revealed
Vietnam’s pharma sector is set to exceed $10B as aging demographics and new regulatory reforms spark rapid growth in the regional healthcare market.
Posted inNews and Updates
Why Nearly 60% of Clinical Trial Sites Fail to Retain Patients
Over half of all clinical trial sites struggle with patient loss due to inefficiencies. Discover the operational fixes needed to boost retention and R&D.
Posted inNews and Updates
ORIC Launches Phase 3 Trial of Rinzimetostat for mCRPC
ORIC Pharmaceuticals has launched the Phase 3 Himalayas-1 trial, testing rinzimetostat as a targeted treatment for metastatic castration-resistant prostate cancer.
Posted inNews and Updates
Lung Cancer Breakthrough: Sac-TMT Shows Promise in NSCLC
New clinical trial data shows the combination of sac-TMT and pembrolizumab hits primary endpoints for patients with PD-L1-negative NSCLC. Read more here.
Posted inNews and Updates
Digital Twins: How Simulation is Transforming Drug Research
Discover how clinical trial simulation and digital twins are slashing R&D costs and accelerating drug development by replacing traditional research models.